Posted On: 12/03/2014 10:43:16 AM
Post# of 7769
Alleyba, good to see you posting again. $60M+ annual run rate and profitable are two characteristics of a company moving forward. I agree the SeeThruEquity is conservative. Also, I feel with the imminent launch of RapiMeds, and the expansion into other States with compounding, the $60M+ 2015 annual run rate projection is also very conversation. This company is on the verge of greatness and I do believe will be one of the biggest success stories for 2015. The current pps of .115 is an incredible buying opportunity for any investor looking for long term profitability.
(0)
(0)
Scroll down for more posts ▼